Site US1680 — Lancaster, Pennsylvania

Site US1680 is a clinical research site located in Lancaster, Pennsylvania, United States 17604.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US1680 has participated in 1 clinical trials.

Therapeutic areas: Prostatic Neoplasms.

Sponsors: Astellas Pharma Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lancaster

Browse all research sites in Pennsylvania · View every site in Lancaster

• Lancaster General Hospital Ann B Barshinger Cancer Institute
• University of Maryland Amish Research Clinic
• Penn Med. Lancaster Gen Hospital
• Lancaster General Hospital
• Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute
• Lancaster General Health Hospital
• Penn State Hershey Children's Hospital-Lancaster Outpatient
• University of Maryland Amish Research
• Lancaster General Hospital/The Heart Group of Lancaster
• Ann B. Barshinger Cancer Institute / Lancaster General Hospital
• Penn Medicine Lancaster General Hospital
• Lancaster Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US1680?

Site US1680 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US1680 conducted?

Site US1680 has 1 clinical trials on record. Their work covers Prostatic Neoplasms.

Is Site US1680 accredited by Crixeo Clinical Trials?

Site US1680 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US1680?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.